Staphylococcus aureus bacterium can colonise in several people without causing any disease. However, in some cases, especially when the immune system is weakened, the bacterium can cause wound infections, pneumonia and meningitis. A particular problem here is that some variants of the bacterium are resistant to antibiotics.
In order to circumvent this resistance and increase the antibiotic effect, researchers are looking for new approaches. One of these approaches is to use so-called helper substances that are assumed to increase the effectiveness of an antibiotic.
Researchers at the University of Southern Denmark recently discovered that cannabidiol (CBD) in combination with the antibiotic bacitracin may be able to fight the Staphylococcus aureus bacterium.
In conclusion, this CBD-bacitracin combination was able to prevent the bacterium from dividing, resulting in an unstable bacterial membrane. According to the researchers, the reduced administration of antibiotics could prevent further resistances.